Oral Anabolic Steroids Exemestane Aromasin for muscle building
Product description
Exemestane Was first listed in the US market in 2000 and was approved by the FDA shortly before 1999. The main purpose of using the same AI is to combat breast cancer in postmenopausal women. Soon after, AI will begin to gain a lot of awareness of synthetic metabolic steroids to prevent its side effects associated with estrogen. This action is very similar to the older and more popular AI in Arimidex and Femara. In steroid users, it will also get a lot of popularity in the Post Cycle Therapy (PCT) program. This is not the first AI to get such popularity, but for this purpose they are more advantageous than most people's AI
Exxamate is formally classified as a steroid suicide aromatase inhibitor and has the ability to inhibit aromatase, which is responsible for the production or transformation of testosterone into estrogen. Aromatic compounds have the ability to prevent aromatization, which in turn inhibits estrogen production, thereby reducing serum estrogen levels.This is useful for patients with breast cancer because breast cancer usually excludes estrogen. It will also be useful for synthetic metabolic steroid users.
cancer cells may grow slower or completely stop growing.
Third-generation aromatase inhibitors for the treatment of metastatic breast cancer and as adjunctive treatment for early breast cancer.
Many breast cancers are stimulated by estrogen estrogen and progesterone. These breast carcinomas are known as hormone-sensitive or hormone-receptor-positive and can be treated with drugs that block the effects of these hormones.
In menopausal women, estrogen is produced primarily by converting androgen (an adrenal gonadotropin) to estrogen. This process is called aromatization, mainly in adipose tissue, muscle and skin. It requires a specific enzyme called an aromatase.
Product application
Exemestane Can be used to resist breast cancer, and increase the body's testosterone.
Acetylacetate prevents the aromatization process. So it reduces the amount of estrogen in the body. In early breast cancer, taking exemestane can help prevent breast cancer recurrence. In advanced breast cancer, cancer cells may grow slower or completely stop growing.
How does Exemestane work?
Many breast cancers are stimulated by estrogen estrogen and progesterone. These breast carcinomas are known as hormone-sensitive or hormone-receptor-positive and can be treated with drugs that block the effects of these hormones.
In menopausal women, estrogen is produced primarily by converting androgen (an adrenal gonadotropin) to estrogen. This process is called aromatization, mainly in adipose tissue, muscle and skin. It requires a specific enzyme called an aromatase.
Exemestate has prevented the fragrance process. So it reduces the amount of estrogen in the body. In early breast cancer, taking exemestane can help prevent breast cancer recovery. In advanced breast cancer, cancer cells may grow slower or completely stop growing.
Benefitf of Exemestane
Exemestane In 1998, a large IES (Intergroup Exemestane Study) trial was conducted and compared with tamoxifen for 3 years after taking tamoxifen for 3 years and converted to aromatase. The results showed that taking tamoxifen 2 to 3 years later (taking hormone therapy for a total of 5 years), 2 to 3 years to switch to amoxacin than stay in tamoxifen 5 years better:
Increase the time before cancer recurrence
Reduce the risk of new breast cancer in new breast cancer
Diagnosis of hormone receptor positive, early breast cancer in postmenopausal women.
A study published in 2011 showed that aromatase can reduce the risk of breast cancer without being diagnosed with high risk of postmenopausal women. Aromasin is not approved by FDA for this purpose, but the doctor may think it is a good substitute for tamoxifen or Evista. In 2013, the American Society of Clinical Oncology (ASCO) published a new guide on the use of hormone therapy to reduce the risk of breast cancer in high risk women. These guidelines suggest that doctors talk with high risk of postmenopausal women about using aromatase to reduce risk. ASCO is a national organization for oncologists and other cancer care providers. The ASCO guidelines provide physicians with reliable research and experience-supported treatment options.
FDA may approve the use of Aromasin to reduce the risk of newly diagnosed high risk, postmenopausal women.
How long do I take Exemestane?
In most cases you will take Aromasin 2 or 3 years. The doctor may suggest that some women take a long time.
Welcome to contact Miss Alsia
Skype:live:mxy04
Email:marc@chembj.com
Whatsapp:+8615107134681
Mobilephone:+8615107134681
facebook:www.facebook.com/alisa.lee.58118
Hit the link, you will find more steroid products.
评论
发表评论